Inhibikase Therapeutics Price Chart
Inhibikase Therapeutics Volume Chart
Inhibikase Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
+0.03(+1.60%)
| Open | $1.67 |
|---|---|
| Close | $1.70 |
| Low | $1.67 |
| Low Change | 0.00 (0.00%) |
| High | $1.70 |
| High Change | +0.03 (+1.60%) |
| Range | $0.03 |
| Volume | 48.706K |
| Dollar Volume | $82.64K |
Regular Trading Hours
-0.01(-0.30%)
| Open | $1.67 |
|---|---|
| Close | $1.67 |
| Low | $1.65 |
| Low Change | -0.02 (-1.20%) |
| High | $1.73 |
| High Change | +0.06 (+3.59%) |
| Range | $0.08 |
| Volume | 313.989K |
| Dollar Volume | $522.79K |
Premarket
+0.00(+0.00%)
| Open | $1.69 |
|---|---|
| Close | $1.69 |
| Low | $1.69 |
| Low Change | 0.00 (0.00%) |
| High | $1.69 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 609 |
| Dollar Volume | $1.03K |
After Hours Yesterday
+0.05(+2.93%)
| Open | $1.67 |
|---|---|
| Close | $1.72 |
| Low | $1.67 |
| Low Change | 0.00 (0.00%) |
| High | $1.72 |
| High Change | +0.05 (+2.99%) |
| Range | $0.05 |
| Volume | 29.867K |
| Dollar Volume | $51.34K |
Regular Trading Hours Yesterday
+0.00(+0.00%)
| Open | $1.68 |
|---|---|
| Close | $1.68 |
| Low | $1.67 |
| Low Change | -0.02 (-0.89%) |
| High | $1.72 |
| High Change | +0.04 (+2.38%) |
| Range | $0.06 |
| Volume | 388.545K |
| Dollar Volume | $652.76K |
Premarket Yesterday
-0.00(-0.07%)
| Open | $1.70 |
|---|---|
| Close | $1.70 |
| Low | $1.67 |
| Low Change | -0.03 (-1.76%) |
| High | $1.71 |
| High Change | +0.01 (+0.59%) |
| Range | $0.04 |
| Volume | 1.3K |
| Dollar Volume | $2.21K |
Inhibikase Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.66 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.67 |
| 20 Day Moving Average (SMA20) | $1.68 |
| 50 Day Moving Average (SMA50) | $1.78 |
| 100 Day Moving Average (SMA100) | $1.78 |
| 200 Day Moving Average (SMA200) | $1.71 |
Inhibikase Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Inhibikase Therapeutics Stock Splits
There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 30, 2023 | Reverse | 6:1 |
Inhibikase Therapeutics Dividends
There have been no dividends for Inhibikase Therapeutics (IKT).